These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 23924152)

  • 21. Medical therapy for benign prostatic hyperplasia: a review.
    Van Asseldonk B; Barkin J; Elterman DS
    Can J Urol; 2015 Oct; 22 Suppl 1():7-17. PubMed ID: 26497339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benign prostatic hyperplasia: mode of presentation and postoperative outcome.
    Khan M; Khan AL; Khan S; Nawaz H
    J Pak Med Assoc; 2005 Jan; 55(1):20-3. PubMed ID: 15816691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of delaying 5-alpha reductase inhibitor therapy in men on alpha-blocker therapy to treat BPH: assessment of acute urinary retention and prostate-related surgery.
    Naslund M; Eaddy MT; Hogue SL; Kruep EJ; Shah MB
    Curr Med Res Opin; 2009 Nov; 25(11):2663-9. PubMed ID: 19757985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benign Prostatic Hyperplasia.
    Langan RC
    Prim Care; 2019 Jun; 46(2):223-232. PubMed ID: 31030823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Benign hypertrophy of the prostate: which treatment, for whom?].
    Schulman C
    Rev Med Brux; 1999 Sep; 20(4):A212-8. PubMed ID: 10523895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute urinary retention increases the risk of complications after transurethral resection of the prostate: a population-based study.
    Chen JS; Chang CH; Yang WH; Kao YH
    BJU Int; 2012 Dec; 110(11 Pt C):E896-901. PubMed ID: 23035623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
    Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG
    Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination therapies for improved management of lower urinary tract symptoms/benign prostatic hyperplasia.
    De Nunzio C; Presicce F; Tubaro A
    Drugs Today (Barc); 2016 Sep; 52(9):501-517. PubMed ID: 27883117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of medical and surgical therapies for lower urinary tract symptoms in the community setting.
    Krambeck AE; Jacobson DJ; McGree ME; Lightner DJ; Lieber MM; Jacobsen SJ; St Sauver JL
    BJU Int; 2012 Nov; 110(9):1332-7. PubMed ID: 22471348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of medical therapy on transurethral resection of the prostate: a decade of change.
    Borth CS; Beiko DT; Nickel JC
    Urology; 2001 Jun; 57(6):1082-5; discussion 1085-6. PubMed ID: 11377312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of transurethral resection of prostate in clinical benign prostatic hyperplasia.
    Bozdar HR; Memon SR; Paryani JP
    J Ayub Med Coll Abbottabad; 2010; 22(4):194-6. PubMed ID: 22455296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glomerulation observed during transurethral resection of the prostate for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia is a common finding but no predictor of clinical outcome.
    Furuya R; Masumori N; Furuya S; Oda T; Takahashi S; Takeuchi M
    Urology; 2007 Nov; 70(5):922-6. PubMed ID: 18068448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Quality of life in patients with lower urinary tract symptoms after TURP for benign prostatic hyperplasia].
    Pushkar DY; Bernikov AN; Khodyreva LA; Dudareva AA; Al'-Shukri SK; Amdii RE; Aboyan IA; Shiranov KA; Medvedev VL; Efremov ME
    Urologiia; 2018 Mar; (1):53-61. PubMed ID: 29634135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defining and discriminating responders from non-responders following transurethral resection of the prostate.
    Sagen E; Hedelin H; Nelzén O; Peeker R
    Scand J Urol; 2018; 52(5-6):437-444. PubMed ID: 30681023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bipolar transurethral vaporization: a superior procedure in benign prostatic hyperplasia: a prospective randomized comparison with bipolar TURP.
    Falahatkar S; Mokhtari G; Moghaddam KG; Asadollahzade A; Farzan A; Shahab E; Ghasemi A; Allahkhah A; Esmaeili S
    Int Braz J Urol; 2014; 40(3):346-55. PubMed ID: 25010300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Twelve-month medication persistence in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Koh JS; Cho KJ; Kim HS; Kim JC
    Int J Clin Pract; 2014 Feb; 68(2):197-202. PubMed ID: 24372906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical treatment of lower urinary tract symptoms/benign prostatic hyperplasia: anything new in 2015.
    Schauer I; Madersbacher S
    Curr Opin Urol; 2015 Jan; 25(1):6-11. PubMed ID: 25393269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Transurethral resection of the prostate in the treatment of benign prostatic hyperplasia].
    Bardos A; Hornak M; Novotny V
    Bratisl Lek Listy; 2001; 102(2):79-83. PubMed ID: 11396128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of Benign Prostatic Hyperplasia.
    Kim EH; Larson JA; Andriole GL
    Annu Rev Med; 2016; 67():137-51. PubMed ID: 26331999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.